Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis.
Saved in:
| Title: | Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis. |
|---|---|
| Authors: | Tsakok T; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.; St John's Institute of Dermatology, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom., Wilson N; Institute of Health and Society, Faculty of Medical Sciences, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Dand N; Department of Medical and Molecular Genetics, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Loeff FC; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam, the Netherlands., Bloem K; Biologics Lab, Sanquin Diagnostic Services, Amsterdam, the Netherlands., Baudry D; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Duckworth M; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Pan S; Infection, Immunity, Inflammation Section, University College London Great Ormond Street Institute of Child Health, London, United Kingdom., Pushpa-Rajah A; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Standing JF; Infection, Immunity, Inflammation Section, University College London Great Ormond Street Institute of Child Health, London, United Kingdom., de Vries A; Biologics Lab, Sanquin Diagnostic Services, Amsterdam, the Netherlands., Alsharqi A; Department of Dermatology, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, United Kingdom., Becher G; West Glasgow Ambulatory Care Hospital, Glasgow, United Kingdom., Murphy R; Department of Dermatology, Queens Medical Centre, Nottingham University Teaching Hospitals, Nottingham, United Kingdom., Wahie S; Department of Dermatology, University Hospital of North Durham, Durham, United Kingdom., Wright A; Centre for Skin Sciences, University of Bradford, Bradford, United Kingdom., Griffiths CEM; Dermatology Centre, Salford Royal National Health Service Foundation Trust, Manchester, United Kingdom.; The University of Manchester, Manchester Academic Health Science Centre, National Institute for Health Research Manchester Biomedical Research Centre, Manchester, United Kingdom., Reynolds NJ; Dermatology Sciences, Institute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom.; Department of Dermatology, Royal Victoria Infirmary, Newcastle Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom., Barker J; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.; St John's Institute of Dermatology, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom., Warren RB; Dermatology Centre, Salford Royal National Health Service Foundation Trust, Manchester, United Kingdom., Burden AD; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom., Rispens T; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam, the Netherlands., Stocken D; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom., Smith C; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.; St John's Institute of Dermatology, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom. |
| Corporate Authors: | British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR) Study Group and the Psoriasis Stratification to Optimise Relevant Therapy (PSORT) Consortium |
| Source: | JAMA dermatology [JAMA Dermatol] 2019 Nov 01; Vol. 155 (11), pp. 1235-1243. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6084 |
|---|---|
| DOI: | 10.1001/jamadermatol.2019.1783 |
